{
    "clinical_study": {
        "@rank": "1384", 
        "acronym": "BISTRO", 
        "biospec_descr": {
            "textblock": "2 5ml serum sample for proteine S100Beta and copeptine analysis"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "We study the hypothesis that combination of Proteine S100 beta and Copeptin within normal\n      ranges can rule out seizure recurrences and severe outcome, and allow early discharge from\n      the emergency department"
        }, 
        "brief_title": "Biomarkers In Seizure To Predict Recurrence and Severe Outcomes", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "condition": [
            "Seizures", 
            "S-100b Protein", 
            "Copeptin"
        ], 
        "condition_browse": {
            "mesh_term": "Seizures"
        }, 
        "detailed_description": {
            "textblock": "Prospective study for a 12 month period in Paris (France) and London (UK).\n\n      Inclusion criteria :\n\n        -  seizure within 24h of attendance to an Emergency department (ED)\n\n        -  or seizure in the ED\n\n      Exclusion Criterie :\n\n        -  pregnancy\n\n        -  prisoneer\n\n      Primary endpoint :\n\n      - recurrence of seizure, hospitalisation more than 24 hours or death within seven days\n\n      Secondary endpoint :\n\n        -  Hospital free days at day 7  and day 28\n\n        -  Death, ICU admission, or neurosurgical intervention at day 7 and day 28\n\n        -  Return visit to the ED or re admission at day 7 and day 28\n\n      data collection:\n\n        -  demographics\n\n        -  past medical history, medication\n\n        -  vital signs (Heart rate, temperature, Pulse oxymetry, blood pressure, GCS) on arrival\n\n        -  Pathology (White cell count, Sodium, Calcium, Glucose, lactate)\n\n        -  Protein S100B and Copeptin\n\n        -  Seizure characteristics (Witnessed, simple, partial, complex, provoked, acute\n           symptomatic, idiopathic)\n\n        -  Discharge plan, outcomes\n\n      Follow up at day 7 and day 28, hospital visit or phone call"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Seizure within 24 hours of ED attendance\n\n          -  Or Seizure in the ED\n\n        Exclusion Criteria:\n\n          -  Pregnancy\n\n          -  Prisoner\n\n          -  age < 18 years old"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Emergency department patients"
            }
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01774500", 
            "org_study_id": "BISTRO"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "biomarkers", 
            "Emergency Department", 
            "Seizures", 
            "epilepsy", 
            "S100b", 
            "copeptin"
        ], 
        "lastchanged_date": "March 26, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75013"
                    }, 
                    "name": "Groupe Hospitalier pitie-salpetriere"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75020"
                    }, 
                    "name": "Hopital Tenon"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75010"
                    }, 
                    "name": "Hopital Lariboisiere"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "E1 1BB"
                    }, 
                    "name": "Royal London Hospital, Barts Health NHS Trust"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "France", 
                "United Kingdom"
            ]
        }, 
        "number_of_groups": "1", 
        "official_title": "Study of Prognosis Value of Protein S100Beta and Copeptine in Seizure in the Emergency Department", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "France : comite for Protection of personnes", 
                "United Kingdom : Research Ethics comitee"
            ]
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Combined hospital admission, seizure recurrence, or death at day 7", 
            "safety_issue": "No", 
            "time_frame": "7 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01774500"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Bistro Study Group", 
            "investigator_full_name": "Yonathan Freund", 
            "investigator_title": "Chef de Clinique  - Research fellow. MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "number of days out of hospital, death corresponding to 0", 
                "measure": "Hospital free days", 
                "safety_issue": "No", 
                "time_frame": "7 days"
            }, 
            {
                "measure": "Hospital free days", 
                "safety_issue": "No", 
                "time_frame": "day 28"
            }, 
            {
                "measure": "death or ICU admission", 
                "safety_issue": "No", 
                "time_frame": "day 7"
            }, 
            {
                "measure": "Death or ICU admission", 
                "safety_issue": "No", 
                "time_frame": "28 days"
            }, 
            {
                "measure": "Recurrence of seizure", 
                "safety_issue": "No", 
                "time_frame": "7 days"
            }
        ], 
        "source": "Bistro Study Group", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Groupe Hospitalier Pitie-Salpetriere", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Barts & The London NHS Trust", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Bistro Study Group", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "1 Month", 
        "verification_date": "March 2014"
    }
}